Table 2.

Comparison of SyMRI parameters of TSC patients and healthy controls

Variables	Healthy controls		Tuberous sclerosis		p-values
	Median	Min–max	Median	Min–max
BPV (ml)	1278	1125–1502	1202	1033–1476	.860
ICV (ml)	1400	1235–1599	1399	1176–1629	.705
WM (ml)	378	301–550	398	343–538	.561
GM (ml)	855	707–1012	821	727–996	.820
CSF (ml)	109	75–309	91	66–212	.561
MY (ml)	109	81–138	93	85–113	.118
Non-WM/GM/CSF (ml)	15	7.7–65	20	15–43	.035*
%Non/BPV	1.15	0.6–4.7	1.6	1.1–3.1	.049*
%MY/ICV	7.8	6.4–9.4	6.7	5.9–9	.05*
%MY/BPV	8.7	6.9–10	7.7	6.8–9.7	.035*
%Non/ICV	1.1	0.6–4.3	1.5	1–2.7	.050*
R NABP MyC	28.55	24.8–34.8	25.6	22–30	.035*
R NABP PD	66.9	62.8–69.4	68.9	66–71.2	.023*
L NABP MyCvol	0.18	0.10–0.20	0.16	0.14–0.19	.017*
L NABP MyC	28.5	24.6–32.3	26	23.5–29.9	.001*
L NABP PD	66.9	64–69	68.6	66–70	.001*
R Caudate MyC	7.2	4.5–8.7	5.35	2–7.3	.004*
R Caudate PD	81	79.8–82.7	82.2	80.8–86.7	.005*
L Caudate MyC	5.2	1–8.3	7.2	5.7–10	.004*
L Caudate PD	80.7	79.1–82	81.9	79.5–85.4	.023*
L Thalamus MyCvol	0.07	0.04–0.10	0.055	0.03–0.09	.009*
Pons MyCvol	0.09	0.07–0.12	0.07	0.06–0.09	.000*
Pons MYC	21.85	18–29	16.7	13.6–20.4	.000*
Pons PD	70.95	66.1–74	74.7	69.4–76.7	.002*

Units: MY (ml), R1 and R2 (s-1), BPV (ml), ICV (ml), WM (ml), GM (ml), PD (pu)

*Represents significance is < 0.05